Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study

References

• Srivastava A, Santagostino E, Dougall A, et al. W.F.H.G.f.t.M.o.H. panelists, a. co, WFH Guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1–158.
   PubMedGoogle Scholar
• Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, et al. Joint protection in haemophilia. Haemophilia. 2011;17(Suppl 2):1–23.
   PubMed Web of Science ®Google Scholar
• Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia. 2006;12(Suppl 3):117–121.
   PubMed Web of Science ®Google Scholar
• Beeton K. Evaluation of outcome of care in patients with haemophilia. Haemophilia. 2002;8:428–434.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yang L, Long C, et al. Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi Province. Expert Rev Hematol. 2015;8:543–550. doi:10.1586/17474086.2015.1043263.
   PubMed Web of Science ®Google Scholar
• Soucie JM, Grosse SD, Siddiqi AE, et al. The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States. Haemophilia. 2017;23:e287–e293.
   PubMed Web of Science ®Google Scholar
• Miesbach W, Kittler S, Bauhofer A, et al. Long-term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A. Haemophilia. 2020;26:467–477. doi:10.1111/hae.13988.
   PubMedGoogle Scholar
• Pasina L, Marengoni A, Ghibelli S, et al. A multicomponent intervention to optimize psychotropic Drug prescription in elderly nursing home residents: An Italian multicenter, prospective, pilot study. Drugs Aging. 2016;33:143–149. doi:10.1007/s40266-015-0336-z.
   PubMed Web of Science ®Google Scholar
• Shapiro AD. Why is primary prophylaxis underutilized in the United States? Haemophilia. 2003;9:670–672.
   PubMed Web of Science ®Google Scholar
• Blanchette VS, Key NS, Ljung LR, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12:1935–1939. doi:10.1111/jth.12672.
   PubMed Web of Science ®Google Scholar
• Martinoli C, Della Casa Alberighi O, Di Minno G, et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost. 2013;109:1170–1179. doi:10.1160/TH12-11-0874.
   PubMed Web of Science ®Google Scholar
• Di Minno MND, Pasta G, Airaldi S, et al. Ultrasound for early detection of joint disease in patients with hemophilic arthropathy. J Clin Med. 2017;6(8):77. doi:10.3390/jcm6080077.
   Web of Science ®Google Scholar
• Banchev A, Stoyanova D, Konstantinov D, et al. Beyond the bleeding rates- HEAD-US joint assessment in patients treated by late prophylaxis. Haemophilia. 2019;25:e294–e297.
   PubMed Web of Science ®Google Scholar
• Timmer MA, Foppen W, Schutgens RE, et al. Comparing findings of routine haemophilia joint Health Score and haemophlia early arthropathy detection with ultrasound assessments in adults with haemophilia. Haemophilia. 2017;23:e141–e143.
   PubMed Web of Science ®Google Scholar
• Måseide RJ, Berntorp E, Astermark J, et al. Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study. Haemophilia. 2021;27:e253–e259. doi:10.1111/hae.14261.
   PubMed Web of Science ®Google Scholar
• Li J, Liu W, Guo XJ, et al. [HEAD-US-C quantitative ultrasound assessment scale in evaluation of joint damage in patients with moderate or severe hemophilia A received on-demand versus prophylaxis replacement therapy]. Zhonghua Xue Ye Xue Za Zhi. 2018;39:817–821.
   PubMedGoogle Scholar
• Zhang CM, Zhang JF, Xu J, et al. Musculoskeletal ultrasonography for arthropathy assessment in patients with hemophilia. Medicine (Baltimore). 2018;97:e13230), doi:10.1097/MD.0000000000013230.
   PubMed Web of Science ®Google Scholar
• Prasetyo M, Moniqa R, Tulaar A, et al. Correlation between Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score and Hemophilia Joint Health Score (HJHS) in patients with hemophilic arthropathy. PLoS One. 2021;16:e0248952.
   PubMed Web of Science ®Google Scholar
• Hilliard P, Funk S, Zourikian N, et al. Hemophilia joint health score reliability study. Haemophilia. 2006;12:518–525.
   PubMed Web of Science ®Google Scholar
• Feldman BM, Funk SM, Bergstrom BM, et al. Validation of a new pediatric joint scoring system from the international Hemophilia prophylaxis study group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken). 2011;63:223–230. doi:10.1002/acr.20353.
   PubMed Web of Science ®Google Scholar
• Sun J, Hilliard PE, Feldman BM, et al. Chinese hemophilia joint health score 2.1 reliability study. Haemophilia. 2014;20:435–440.
   PubMed Web of Science ®Google Scholar
• Duncan N, Kronenberger W, Roberson C, et al. VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Haemophilia. 2010;16:247–255.
   PubMed Web of Science ®Google Scholar
• Ferreira AA, Leite ICG, Duncan NA. Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia. Rev Bras Hematol Hemoter. 2018;40:18–24.
   PubMedGoogle Scholar
• Cuesta-Barriuso R, Torres-Ortuño A, Galindo-Piñana P, et al. Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia. Patient Prefer Adherence. 2017;11:653–660.
   PubMed Web of Science ®Google Scholar
• De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, et al. HJHS 2.1 and HEAD-US assessment in the hemophilic joints: How do their findings compare? Blood Coagul Fibrinolysis. 2020;31:387–392. doi:10.1097/MBC.0000000000000934.
   PubMed Web of Science ®Google Scholar
• Sluiter D, Foppen W, de Kleijn P, et al. Haemophilia joint health score in healthy adults playing sports. Haemophilia. 2014;20:282–286.
   PubMed Web of Science ®Google Scholar
• Altisent C, Martorell M, Crespo A, et al. Early prophylaxis in children with severe haemophilia A: clinical and ultrasound imaging outcomes. Haemophilia. 2016;22:218–224.
   PubMed Web of Science ®Google Scholar
• De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, et al. The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with hemophilia. Expert Rev Hematol. 2018;11:253–261. doi:10.1080/17474086.2018.1435269.
   PubMed Web of Science ®Google Scholar
• Kavaklı K, Özbek SS, Antmen AB, et al. Impact of the HEAD-US scoring system for observing the protective effect of prophylaxis in Hemophilia patients: A Prospective, multicenter, observational study. Turkish Journal of Hematology. 2021;38:101–110. doi:10.4274/tjh.galenos.2021.2020.0717.
   PubMed Web of Science ®Google Scholar
• Warren BB, Thornhill D, Stein J, et al. Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the joint outcome continuation study. Blood Advances. 2020;4:2451–2459. doi:10.1182/bloodadvances.2019001311.
   PubMed Web of Science ®Google Scholar
• Khair K, Holland M, Bladen M, et al. Study of physical function in adolescents with haemophilia: The SO-FIT study. Haemophilia. 2017;23:918–925.
   PubMedGoogle Scholar